Cassava Sciences, Inc.
SAVA
$3.10
$0.217.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 75.56% | -88.97% | 15.20% | 1.24% | -553.99% |
| Total Depreciation and Amortization | -39.91% | -0.91% | -15.38% | 0.39% | -14.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.91% | -12.33% | -9.04% | 2.43% | 108.97% |
| Change in Net Operating Assets | -99.85% | 420.66% | 116.69% | -1,149.52% | -90.01% |
| Cash from Operations | -25.75% | 56.36% | 81.50% | -234.85% | -0.30% |
| Capital Expenditure | -- | -- | -- | -235.29% | 41.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -235.29% | 41.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -90.20% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -90.20% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.37% | 56.01% | 81.38% | -229.84% | -122.03% |